Maintaining quality of life for patients with neuroendocrine tumours-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Maintaining quality of life for patients with neuroendocrine tumours

Published:2017-10 Issue:10 Volume:18 Page:1299-1300
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Walter Thomas

Publisher

Elsevier BV

Subject

Oncology

Reference9 articles.

1. Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial;Gourgou-Bourgade;J Clin Oncol,2013

2. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

3. Everolimus for advanced pancreatic neuroendocrine tumors;Yao;N Engl J Med,2011

4. Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study;Yao;Lancet,2016

5. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors;Raymond;N Engl J Med,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network;Journal of Nuclear Medicine;2024-08-01

2. Current perspectives on neuroendocrine tumors;hLife;2024-07

3. A practical proposal on treatment sequencing of metastatic well-differentiated neuroendocrine tumours;Therapeutic Advances in Medical Oncology;2023-01

4. Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal study;Journal of Endocrinological Investigation;2022-07-22

5. Health-related quality of life in patients with advanced well-differentiated pancreatic and extrapancreatic neuroendocrine tumors treated with surufatinib versus placebo: Results from two randomized, double-blind, phase III trials (SANET-p and SANET-ep);European Journal of Cancer;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3